Lundbeck (LUN.CO)

Nasdaq Copenhagen · Pharmaceutical industry · Financial statements, TTM figures and earnings dates

In fiscal year 2025 (ended December 31, 2025), Lundbeck reported revenue of DKK 24.63B and net income of DKK 3.19B. Annual financial statements are available for fiscal years 2021 to 2025, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

DKK	FY2025 2025-12-31	FY2024 2024-12-31	FY2023 2023-12-31	FY2022 2022-12-31	FY2021 2021-12-31
Income statement
Revenue	DKK 24.63B	DKK 22.00B	DKK 19.91B	DKK 18.25B	DKK 16.30B
Gross profit	DKK 20.36B	DKK 17.77B	DKK 15.43B	DKK 14.29B	DKK 12.65B
Operating income	DKK 5.28B	DKK 3.27B	DKK 3.19B	DKK 2.85B	DKK 2.01B
Net income	DKK 3.19B	DKK 3.14B	DKK 2.29B	DKK 1.92B	DKK 1.32B
Diluted EPS	DKK 3.22	DKK 3.17	DKK 2.31	DKK 1.93	DKK 1.33
Cash flow
Operating cash flow	DKK 5.48B	DKK 3.33B	DKK 4.08B	DKK 3.52B	DKK 2.27B
Capital expenditure	DKK 554.0M	DKK 508.0M	DKK 277.0M	DKK 371.0M	DKK 410.0M
Free cash flow	DKK 4.93B	DKK 2.82B	DKK 3.80B	DKK 3.15B	DKK 1.86B
Balance sheet
Cash and equivalents	DKK 3.43B	DKK 4.66B	DKK 5.01B	DKK 3.55B	DKK 2.28B
Total assets	DKK 52.05B	DKK 57.66B	DKK 37.41B	DKK 37.45B	DKK 34.65B
Total liabilities	DKK 27.15B	DKK 32.65B	DKK 15.36B	DKK 16.67B	DKK 16.37B
Total debt	DKK 11.19B	DKK 16.17B	DKK 3.71B	DKK 5.10B	DKK 4.78B
Shareholders' equity	DKK 24.90B	DKK 25.01B	DKK 22.05B	DKK 20.78B	DKK 18.28B

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in DKK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full LUN.CO page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open LUN.CO financials →